Publications
- Validation of shortened 2-day sterility testing of mesenchymal stem cell-based therapeutic preparation on an automated culture system2016 | Faculty of Medicine in Pilsen
- Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia2016 | Faculty of Medicine in Pilsen
- The Quality Control of Mesenchymal Stromal Cells by in Vitro Testing of Their Immunomodulatory Effect on Allogeneic Lymphocytes2016 | Faculty of Medicine in Pilsen
- The impact of standard chemotherapy on miRNA signature in plasma in AML patients2015 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab2013 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Intra- and Interlaboratory Variability of Paroxysmal Nocturnal Hemoglobinuria Testing by Flow Cytometry Following the 2012 Practical Guidelines for High-Sensitivity Paroxysmal Nocturnal Hemoglobinuria Testing2013 | Faculty of Medicine in Pilsen
- Diagnosing celiac disease in patients with a history of lymphoma: factors that matter2013 | Faculty of Medicine in Pilsen
- Immunomodulative effect of mesenchymal stem cells on nonspecifcaly induced lymphocyte proliferation2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...
